BRCA1-deficient breast cancers with PTEN mutation generally had higher T cell-inflamed signature scores compared to BRCA1-proficient breast cancers and BRCA1-deficient breast cancers without PTEN mutation (Fig 4F). The gene discussed is PTEN; the disease is breast carcinoma.